Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Triple Negative Breast Neoplasms"" wg kryterium: Temat


Tytuł :
Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells.
Autorzy :
Barreca M; Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123, Palermo, Italy.
Ingarra AM; Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123, Palermo, Italy.
Raimondi MV; Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123, Palermo, Italy.
Spanò V; Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123, Palermo, Italy. Electronic address: .
De Franco M; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35128, Padova, Italy.
Menilli L; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35128, Padova, Italy.
Gandin V; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35128, Padova, Italy.
Miolo G; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35128, Padova, Italy.
Barraja P; Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123, Palermo, Italy.
Montalbano A; Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, 90123, Palermo, Italy.
Pokaż więcej
Źródło :
European journal of medicinal chemistry [Eur J Med Chem] 2022 Jul 05; Vol. 237, pp. 114399. Date of Electronic Publication: 2022 Apr 18.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Indolizines*/pharmacology
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/metabolism
Apoptosis ; Azepines/pharmacology ; Cell Line, Tumor ; Humans ; Photosensitizing Agents/pharmacology ; Photosensitizing Agents/therapeutic use
Czasopismo naukowe
Tytuł :
In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.
Autorzy :
Ji P; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Gong Y; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Jin ML; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Wu HL; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Guo LW; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Pei YC; Precision Cancer Medical Center, Fudan University Shanghai Cancer Center, Shanghai 201315, China.
Chai WJ; Laboratory Animal Center, Fudan University Shanghai Cancer Center, Shanghai 201315, China.
Jiang YZ; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Liu Y; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Ma XY; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Di GH; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Hu X; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Precision Cancer Medical Center, Fudan University Shanghai Cancer Center, Shanghai 201315, China.
Shao ZM; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Precision Cancer Medical Center, Fudan University Shanghai Cancer Center, Shanghai 201315, China.
Pokaż więcej
Źródło :
Science advances [Sci Adv] 2022 Jul; Vol. 8 (26), pp. eabl8247. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/therapy
Animals ; Clustered Regularly Interspaced Short Palindromic Repeats ; Galectin 2/genetics ; Humans ; Immunotherapy/methods ; Mice ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł :
The risk of PD-L1 expression misclassification in triple-negative breast cancer.
Autorzy :
Ben Dori S; B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Aizic A; Institute of Pathology, Tel-Aviv Sourasky Medical Center, Dafna 5, 6492601, Tel Aviv, Israel.
Zubkov A; Institute of Pathology, Tel-Aviv Sourasky Medical Center, Dafna 5, 6492601, Tel Aviv, Israel.
Tsuriel S; Institute of Pathology, Tel-Aviv Sourasky Medical Center, Dafna 5, 6492601, Tel Aviv, Israel.
Sabo E; B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Institute of Pathology, Carmel Medical Center, Haifa, Israel.
Hershkovitz D; Institute of Pathology, Tel-Aviv Sourasky Medical Center, Dafna 5, 6492601, Tel Aviv, Israel. .; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. .
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jul; Vol. 194 (2), pp. 297-305. Date of Electronic Publication: 2022 May 27.
Typ publikacji :
Journal Article
MeSH Terms :
Triple Negative Breast Neoplasms*/diagnosis
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Humans ; Prognosis
Czasopismo naukowe
Tytuł :
Sacituzumab Govitecan-hziy in Breast Cancer.
Autorzy :
Kwapisz D; University Clinical Center of the Medical University of Warsaw, Warsaw, Poland.
Pokaż więcej
Źródło :
American journal of clinical oncology [Am J Clin Oncol] 2022 Jul 01; Vol. 45 (7), pp. 279-285. Date of Electronic Publication: 2022 May 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunoconjugates*/pharmacology
Immunoconjugates*/therapeutic use
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/pathology
Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Camptothecin/analogs & derivatives ; Camptothecin/therapeutic use ; Humans
Czasopismo naukowe
Tytuł :
Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells.
Autorzy :
Jirapongwattana N; Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Thongchot S; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Chiraphapphaiboon W; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE‑CIT), Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Chieochansin T; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE‑CIT), Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Sa-Nguanraksa D; Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Warnnissorn M; Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Thuwajit P; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Yenchitsomanus PT; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE‑CIT), Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Thuwajit C; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Pokaż więcej
Źródło :
Oncology reports [Oncol Rep] 2022 Jul; Vol. 48 (1). Date of Electronic Publication: 2022 May 26.
Typ publikacji :
Journal Article
MeSH Terms :
Dendritic Cells*/metabolism
Mesothelin*
Ribosomal Proteins*/genetics
Ribosomal Proteins*/metabolism
T-Lymphocytes*/immunology
Triple Negative Breast Neoplasms*/immunology
Triple Negative Breast Neoplasms*/pathology
Cell Line, Tumor ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/metabolism ; Humans
Czasopismo naukowe
Tytuł :
MYB RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish Breast Adenoid Cystic Carcinoma From Other Triple-negative Breast Carcinomas.
Autorzy :
Butcher MR; Departments of Pathology.
White MJ; Departments of Pathology.
Rooper LM; Departments of Pathology.
Argani P; Departments of Pathology.; Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Cimino-Mathews A; Departments of Pathology.; Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Pokaż więcej
Źródło :
The American journal of surgical pathology [Am J Surg Pathol] 2022 Jul 01; Vol. 46 (7), pp. 878-888. Date of Electronic Publication: 2022 May 09.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/pathology
Carcinoma, Adenoid Cystic*/diagnosis
Carcinoma, Adenoid Cystic*/genetics
Carcinoma, Adenoid Cystic*/pathology
Carcinoma, Ductal, Breast*/pathology
Carcinoma, Intraductal, Noninfiltrating*
Salivary Gland Neoplasms*/pathology
Triple Negative Breast Neoplasms*/diagnosis
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Biomarkers, Tumor/genetics ; Female ; Humans ; In Situ Hybridization ; RNA
Czasopismo naukowe
Tytuł :
A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic flux.
Autorzy :
Xiao X; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China; Department of Immunology, Guizhou Medical University, Guiyang 550014, PR China.
Chung PED; Toronto General Research Institute, University Health Network, 67 College Street, Toronto, ON M5G 2M1, Canada; Department of Laboratory Medicine& Pathobiology, University of Toronto, Toronto, ON, Canada.
Xu M; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China.
Hu A; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China.
Ju Y; Toronto General Research Institute, University Health Network, 67 College Street, Toronto, ON M5G 2M1, Canada; Department of Laboratory Medicine& Pathobiology, University of Toronto, Toronto, ON, Canada.
Yang X; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China.
Song J; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China.
Song J; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China.
Wang C; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China.
Zacksenhaus E; Toronto General Research Institute, University Health Network, 67 College Street, Toronto, ON M5G 2M1, Canada; Department of Laboratory Medicine& Pathobiology, University of Toronto, Toronto, ON, Canada. Electronic address: .
Liu S; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China. Electronic address: .
He Z; Key Laboratory of Adult Stem Cell Transformation, Chinese Academy of Medical Sciences, Guiyang 550004, PR China; Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, PR China. Electronic address: .
Ben-David Y; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang 550014, PR China. Electronic address: .
Pokaż więcej
Źródło :
Biochemical pharmacology [Biochem Pharmacol] 2022 Jul; Vol. 201, pp. 115060. Date of Electronic Publication: 2022 May 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lysosomes*
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/metabolism
Autophagy ; Carbazoles ; Cell Line, Tumor ; Female ; Humans ; Indoles/pharmacology
Czasopismo naukowe
Tytuł :
Axillary radiation alone is a suboptimal treatment for ypN + in patients with triple negative breast cancer and axillary lymph node dissection should be considered in this setting.
Autorzy :
Swarnkar PK; GKT School of Medicine, King's College London, Guy's Hospital, Great Maze Pond, SE1 9RT, London, UK. .
Mokbel K; London Breast Institute, Princess Grace Hospital, 42-52 Nottingham Pl, Marylebone, W1U 5NY, London, UK.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jul; Vol. 194 (1), pp. 199. Date of Electronic Publication: 2022 May 03.
Typ publikacji :
Letter
MeSH Terms :
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/radiotherapy
Triple Negative Breast Neoplasms*/surgery
Axilla ; Female ; Humans ; Lymph Node Excision ; Lymph Nodes/pathology ; Lymph Nodes/surgery ; Sentinel Lymph Node Biopsy
Opinia redakcyjna
Tytuł :
Dibenzyl trisulfide induces caspase-independent death and lysosomal membrane permeabilization of triple-negative breast cancer cells.
Autorzy :
Wooten J; Department of Basic Sciences, Loma Linda University Health School of Medicine, Loma Linda, CA, United States of America; Center for Health Disparities and Molecular Medicine, Loma Linda University Health School of Medicine, Loma Linda, CA, United States of America. Electronic address: .
Mavingire N; Department of Basic Sciences, Loma Linda University Health School of Medicine, Loma Linda, CA, United States of America. Electronic address: .
Araújo CA; Department of Basic Sciences, Loma Linda University Health School of Medicine, Loma Linda, CA, United States of America; Center for Health Disparities and Molecular Medicine, Loma Linda University Health School of Medicine, Loma Linda, CA, United States of America. Electronic address: .
Aja J; National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Quezon City, Philippines. Electronic address: .
Wauchope S; Natural Products Institute, University of the West Indies, Mona, Kingston 7, Jamaica. Electronic address: .
Delgoda R; Natural Products Institute, University of the West Indies, Mona, Kingston 7, Jamaica. Electronic address: .
Brantley E; Department of Basic Sciences, Loma Linda University Health School of Medicine, Loma Linda, CA, United States of America; Center for Health Disparities and Molecular Medicine, Loma Linda University Health School of Medicine, Loma Linda, CA, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Fitoterapia [Fitoterapia] 2022 Jul; Vol. 160, pp. 105203. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji :
Journal Article
MeSH Terms :
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Benzyl Compounds ; Caspases/metabolism ; Cell Line, Tumor ; Female ; Humans ; Lysosomes ; Molecular Structure ; Sulfides
Czasopismo naukowe
Tytuł :
Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
Autorzy :
Giatromanolaki A; Department of Pathology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Gkegka AG; Department of Pathology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Pouliliou S; Department of Radiotherapy/Oncology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Biziota E; Department of Medical Oncology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Kakolyris S; Department of Medical Oncology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Koukourakis M; Department of Radiotherapy/Oncology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece. .
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jul; Vol. 194 (1), pp. 13-23. Date of Electronic Publication: 2022 Apr 28.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Tertiary Lymphoid Structures*/pathology
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Anaerobiosis ; Biomarkers, Tumor/metabolism ; Female ; Humans ; Hypoxia/metabolism ; Hypoxia/pathology ; Isoenzymes/metabolism ; Lactate Dehydrogenase 5 ; Lymphocytes, Tumor-Infiltrating ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Prospective Studies ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Subclassifying triple-negative breast cancers and its potential clinical utility.
Autorzy :
Lian J; Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, People's Republic of China.
Ma HX; Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, People's Republic of China.
Xu EW; Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, People's Republic of China.
Bu P; Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, People's Republic of China.
Yun KM; Institute of Forensic Medicine, Shanxi Medical University, Taiyuan, Shanxi Province, People's Republic of China. .
Xi YF; Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, People's Republic of China. .
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2022 Jul; Vol. 481 (1), pp. 13-21. Date of Electronic Publication: 2022 Apr 26.
Typ publikacji :
Journal Article
MeSH Terms :
Triple Negative Breast Neoplasms*/metabolism
Triple Negative Breast Neoplasms*/therapy
B7-H1 Antigen ; Biomarkers, Tumor ; Cohort Studies ; Humans ; Lymphocytes, Tumor-Infiltrating/pathology
Czasopismo naukowe
Tytuł :
The role of GATA3 in the metastasis of triple-negative breast cancer and high-grade serous ovarian cancer.
Autorzy :
El-Arabey AA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. .
Abdalla M; Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Cultural West Road, Shandong, 250012, People's Republic of China.
Pokaż więcej
Źródło :
Human cell [Hum Cell] 2022 Jul; Vol. 35 (4), pp. 1298-1300. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji :
Letter
MeSH Terms :
Cystadenocarcinoma, Serous*/genetics
Cystadenocarcinoma, Serous*/pathology
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/therapy
Biomarkers, Tumor ; Female ; GATA3 Transcription Factor/genetics ; Humans
Opinia redakcyjna
Tytuł :
Cancer stem cells in TNBC.
Autorzy :
Hua Z; Department of General Surgery, China-Japan Friendship Hospital, Beijing, 100029, People's Republic of China.
White J; Tuskegee University, Center for Cancer Research, Tuskegee, AL, 36830, USA.
Zhou J; Research Center for Translational Medicine, Cancer Stem Cell Institute, East Hospital, Tongji University School of Medicine, Shanghai, 200120, People's Republic of China. Electronic address: zhoujj_.
Pokaż więcej
Źródło :
Seminars in cancer biology [Semin Cancer Biol] 2022 Jul; Vol. 82, pp. 26-34. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/therapy
Humans ; Neoplastic Stem Cells/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone ; Signal Transduction ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Ceritinib is a novel triple negative breast cancer therapeutic agent.
Autorzy :
Dong S; TYK Medicines, Inc, Zhejiang, People's Republic of China, 313100.; Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA.
Yousefi H; Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA.
Savage IV; Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA.
Okpechi SC; Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA.
Wright MK; Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA.
Matossian MD; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA.
Collins-Burow BM; Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA.
Burow ME; Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA.
Alahari SK; Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA. .; Stanley S. Scott Cancer Center, LSUHSC School of Medicine, New Orleans, LA, 70112, USA. .
Pokaż więcej
Źródło :
Molecular cancer [Mol Cancer] 2022 Jun 29; Vol. 21 (1), pp. 138. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Androgens/therapeutic use ; Animals ; Cell Line, Tumor ; Humans ; Mice ; Paclitaxel/pharmacology ; Paclitaxel/therapeutic use ; Pyrimidines ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Sulfones
Czasopismo naukowe
Tytuł :
Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro.
Autorzy :
Khan MA; Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, 646000, Sichuan, China. .
Zheng M; Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Fu J; Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Tania M; Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, 646000, Sichuan, China.; Division of Molecular Cancer Biology, The Red-Green Research Center, Dhaka, 1205, Bangladesh.; Nature Study Society of Bangladesh, Dhaka, Bangladesh.
Li J; Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, 646000, Sichuan, China.; Department of Pathology, Baoji Central Hospital, Baoji, 721008, Shaanxi, China.
Fu J; Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, 646000, Sichuan, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2022 Jun 27; Vol. 22 (1), pp. 707. Date of Electronic Publication: 2022 Jun 27.
Typ publikacji :
Journal Article
MeSH Terms :
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Benzoquinones/pharmacology ; Cell Line, Tumor ; Female ; Humans ; Neoplastic Processes ; Receptors, Interleukin/therapeutic use
Czasopismo naukowe
Tytuł :
Chemokine receptors differentially expressed by race category and molecular subtype in the breast cancer TCGA cohort.
Autorzy :
Vazquez ED; Department of Biology, San Francisco State University, San Francisco, CA, 94132, USA.
Fang X; Department of Biology, San Francisco State University, San Francisco, CA, 94132, USA.
Levesque LA; Department of Biology, San Francisco State University, San Francisco, CA, 94132, USA.
Huynh M; Department of Biology, San Francisco State University, San Francisco, CA, 94132, USA.
Venegas C; Department of Biology, San Francisco State University, San Francisco, CA, 94132, USA.
Lu N; Department of Biology, San Francisco State University, San Francisco, CA, 94132, USA.
Salazar N; Department of Biology, San Francisco State University, San Francisco, CA, 94132, USA. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2022 Jun 26; Vol. 12 (1), pp. 10825. Date of Electronic Publication: 2022 Jun 26.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/ethnology
Breast Neoplasms*/metabolism
Breast Neoplasms*/pathology
Receptors, Chemokine*/biosynthesis
Receptors, Chemokine*/genetics
Triple Negative Breast Neoplasms*/ethnology
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Breast/pathology ; Cohort Studies ; Female ; Humans ; Racial Groups
Czasopismo naukowe
Tytuł :
A DNA damage nanoamplifier for the chemotherapy of triple-negative breast cancer via DNA damage induction and repair blocking.
Autorzy :
Huang Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Dai X; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Guan Z; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Liu D; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Ren L; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Chen M; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Zeng Z; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Jiang J; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Luo Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
He Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Huang M; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
Zhao C; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2022 Jun 25; Vol. 622, pp. 121897. Date of Electronic Publication: 2022 Jun 08.
Typ publikacji :
Journal Article
MeSH Terms :
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Cell Line, Tumor ; DNA Damage ; Humans ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Poly(ADP-ribose) Polymerases
Czasopismo naukowe
Tytuł :
Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
Autorzy :
Xia LY; Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Xu WY; Department of Breast Surgery, Mianyang Central Hospital, Mianyang, Sichuan, China.
Zhao Y; Department of Breast Surgery, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2022 Jun 24; Vol. 17 (6), pp. e0270528. Date of Electronic Publication: 2022 Jun 24 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/radiotherapy
Triple Negative Breast Neoplasms*/surgery
Female ; Humans ; Lymph Nodes/pathology ; Mastectomy ; Neoplasm Staging ; Radiotherapy, Adjuvant ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment.
Autorzy :
Yang ZY; Department of Breast Surgery, China-Japan Union Hospital of Jilin University, No.126, Xiantai Street, Changchun, 130033, Jilin, China.
Jiang CW; Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.
Zhang WL; Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.
Sun G; Department of Breast Surgery, China-Japan Union Hospital of Jilin University, No.126, Xiantai Street, Changchun, 130033, Jilin, China. .
Pokaż więcej
Źródło :
Journal of translational medicine [J Transl Med] 2022 Jun 18; Vol. 20 (1), pp. 276. Date of Electronic Publication: 2022 Jun 18.
Typ publikacji :
Journal Article
MeSH Terms :
B7-H1 Antigen*/metabolism
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Animals ; Doxorubicin/pharmacology ; Doxorubicin/therapeutic use ; Humans ; Mice ; Pyridines ; Pyrimidines ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
Autorzy :
Chen X; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China.
Yang M; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China.
Yin J; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China.
Li P; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China.
Zeng S; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China.
Zheng G; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China.
He Z; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China.
Liu H; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China.
Wang Q; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China. .
Zhang F; Department of Pharmacy, Renmin Hospital of Wuhan University, No.99 Zhangzhidong Road, Wuhan, 430000, Hubei, China. .
Chen D; Guangzhou Key Laboratory of 'Translational Medicine on Malignant Tumor Treatment', Affiliated Cancer Hospital & Institute of Guangzhou Medical University, No.78 Hengzhigang Road, Guangzhou, 510095, Guangdong, China. .
Pokaż więcej
Źródło :
Cell communication and signaling : CCS [Cell Commun Signal] 2022 Jun 17; Vol. 20 (1), pp. 92. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji :
Journal Article; Video-Audio Media
MeSH Terms :
Chemokine CCL2*/metabolism
Epithelial-Mesenchymal Transition*
Neoplastic Stem Cells*/metabolism
Neoplastic Stem Cells*/pathology
Proto-Oncogene Proteins c-akt*/metabolism
Triple Negative Breast Neoplasms*/metabolism
Triple Negative Breast Neoplasms*/pathology
Tumor-Associated Macrophages*/metabolism
Tumor-Associated Macrophages*/pathology
beta Catenin*/metabolism
Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Humans ; Signal Transduction ; Tumor Microenvironment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies